跳至主要内容
临床试验/ISRCTN17615029
ISRCTN17615029已完成不适用

Does routine peri-operative continuous cell salvage in cardiac surgery reduce exposure to allogeneic blood? A randomised controlled trial

Papworth Hospital NHS Trust (UK)0 个研究点目标入组 206 人开始时间: 2005年5月24日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
206

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients for non-emergency first-time Coronary Artery Bypass Grafting (CABG) with planned use of cardiopulmonary bypass, and patients for valve repair or replacement, or combined CABG and valve procedure.

排除标准

  • 1. Refusal to receive blood or blood products
  • 2. Previous cardiac or thoracic surgery
  • 3. Having an unacceptable risk, as per investigator judgement
  • 4. Known serious coagulation disorders
  • 5. Known blood disorder (thalassemia, chronic anaemia, lymphoproliferative disorder etc.)
  • 6. Any contra-indication to antifibrinolytics
  • 7. The receipt of any investigational drug or participation in a device trial during the course of this trial
  • 8. Where a specific request for cell salvage has been made by the surgeon

研究者

发起方
Papworth Hospital NHS Trust (UK)

相似试验